UniProt ID | NPM_MOUSE | |
---|---|---|
UniProt AC | Q61937 | |
Protein Name | Nucleophosmin | |
Gene Name | Npm1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 292 | |
Subcellular Localization | Nucleus, nucleolus . Nucleus, nucleoplasm . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Colocalizes w | |
Protein Description | Involved in diverse cellular processes such as ribosome biogenesis, centrosome duplication, protein chaperoning, histone assembly, cell proliferation, and regulation of tumor suppressors p53/TP53 and ARF. Binds ribosome presumably to drive ribosome nuclear export. Associated with nucleolar ribonucleoprotein structures and bind single-stranded nucleic acids. Acts as a chaperonin for the core histones H3, H2B and H4. Stimulates APEX1 endonuclease activity on apurinic/apyrimidinic (AP) double-stranded DNA but inhibits APEX1 endonuclease activity on AP single-stranded RNA. May exert a control of APEX1 endonuclease activity within nucleoli devoted to repair AP on rDNA and the removal of oxidized rRNA molecules. In concert with BRCA2, regulates centrosome duplication. Regulates centriole duplication: phosphorylation by PLK2 is able to trigger centriole replication. Negatively regulates the activation of EIF2AK2/PKR and suppresses apoptosis through inhibition of EIF2AK2/PKR autophosphorylation. Antagonizes the inhibitory effect of ATF5 on cell proliferation and relieves ATF5-induced G2/M blockade. In complex with MYC enhances the transcription of MYC target genes.. | |
Protein Sequence | MEDSMDMDMSPLRPQNYLFGCELKADKDYHFKVDNDENEHQLSLRTVSLGAGAKDELHIVEAEAMNYEGSPIKVTLATLKMSVQPTVSLGGFEITPPVVLRLKCGSGPVHISGQHLVAVEEDAESEDEDEEDVKLLGMSGKRSAPGGGNKVPQKKVKLDEDDEDDDEDDEDDEDDDDDDFDEEETEEKVPVKKSVRDTPAKNAQKSNQNGKDLKPSTPRSKGQESFKKQEKTPKTPKGPSSVEDIKAKMQASIEKGGSLPKVEAKFINYVKNCFRMTDQEAIQDLWQWRKSL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDSMDMD -------CCCCCCCC | 13.41 | - | |
4 | Phosphorylation | ----MEDSMDMDMSP ----CCCCCCCCCCC | 11.90 | 26824392 | |
10 | Phosphorylation | DSMDMDMSPLRPQNY CCCCCCCCCCCCCCE | 19.27 | 23527152 | |
17 | Phosphorylation | SPLRPQNYLFGCELK CCCCCCCEEEEEEEE | 9.73 | 21149613 | |
27 | Acetylation | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | 66695887 | |
27 | Ubiquitination | GCELKADKDYHFKVD EEEEECCCCCEEEEC | 66.11 | - | |
29 | Phosphorylation | ELKADKDYHFKVDND EEECCCCCEEEECCC | 18.20 | 25367039 | |
32 | Acetylation | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | 68491 | |
32 | Ubiquitination | ADKDYHFKVDNDENE CCCCCEEEECCCCCC | 35.05 | - | |
43 | Phosphorylation | DENEHQLSLRTVSLG CCCCEEEEEEEEECC | 14.83 | 24899341 | |
46 | Phosphorylation | EHQLSLRTVSLGAGA CEEEEEEEEECCCCC | 21.53 | 25619855 | |
48 | Phosphorylation | QLSLRTVSLGAGAKD EEEEEEEECCCCCCC | 22.07 | 25619855 | |
54 | Ubiquitination | VSLGAGAKDELHIVE EECCCCCCCEEEEEE | 51.31 | - | |
67 | Phosphorylation | VEAEAMNYEGSPIKV EEEEHHCCCCCCEEE | 14.47 | 25521595 | |
70 | Phosphorylation | EAMNYEGSPIKVTLA EHHCCCCCCEEEEEE | 16.12 | 24925903 | |
75 | Phosphorylation | EGSPIKVTLATLKMS CCCCEEEEEEEEEEE | 12.98 | 26160508 | |
78 | Phosphorylation | PIKVTLATLKMSVQP CEEEEEEEEEEEECC | 29.98 | 19060867 | |
82 | Phosphorylation | TLATLKMSVQPTVSL EEEEEEEEECCEEEE | 18.93 | 26643407 | |
86 | Phosphorylation | LKMSVQPTVSLGGFE EEEEECCEEEECCEE | 12.97 | 23984901 | |
88 | Phosphorylation | MSVQPTVSLGGFEIT EEECCEEEECCEEEC | 24.63 | 26745281 | |
95 | Phosphorylation | SLGGFEITPPVVLRL EECCEEECCCEEEEE | 17.84 | 26745281 | |
106 | Phosphorylation | VLRLKCGSGPVHISG EEEEEECCCCEEECC | 49.77 | 25521595 | |
112 | Phosphorylation | GSGPVHISGQHLVAV CCCCEEECCEEEEEE | 19.95 | 24925903 | |
125 | Phosphorylation | AVEEDAESEDEDEED EEECCCCCCCCCHHH | 52.66 | 24925903 | |
139 | Phosphorylation | DVKLLGMSGKRSAPG HHHHEEECCCCCCCC | 39.09 | 26824392 | |
141 | Acetylation | KLLGMSGKRSAPGGG HHEEECCCCCCCCCC | 35.55 | 68495 | |
141 | Ubiquitination | KLLGMSGKRSAPGGG HHEEECCCCCCCCCC | 35.55 | - | |
143 | Phosphorylation | LGMSGKRSAPGGGNK EEECCCCCCCCCCCC | 42.15 | 25266776 | |
150 | Acetylation | SAPGGGNKVPQKKVK CCCCCCCCCCCCCCC | 59.57 | 68499 | |
154 | Acetylation | GGNKVPQKKVKLDED CCCCCCCCCCCCCCC | 54.16 | 68503 | |
154 | Ubiquitination | GGNKVPQKKVKLDED CCCCCCCCCCCCCCC | 54.16 | - | |
155 | Acetylation | GNKVPQKKVKLDEDD CCCCCCCCCCCCCCC | 39.08 | 7303091 | |
185 | Phosphorylation | DDFDEEETEEKVPVK CCCCHHHHHHCCCCC | 53.37 | 25619855 | |
194 | Phosphorylation | EKVPVKKSVRDTPAK HCCCCCCHHCCCHHH | 19.37 | 25266776 | |
198 | Phosphorylation | VKKSVRDTPAKNAQK CCCHHCCCHHHHHHH | 18.00 | 26824392 | |
206 | ADP-ribosylation | PAKNAQKSNQNGKDL HHHHHHHHCCCCCCC | 31.41 | - | |
211 | Acetylation | QKSNQNGKDLKPSTP HHHCCCCCCCCCCCC | 68.39 | 109345 | |
214 | Acetylation | NQNGKDLKPSTPRSK CCCCCCCCCCCCCCH | 47.24 | - | |
214 | Malonylation | NQNGKDLKPSTPRSK CCCCCCCCCCCCCCH | 47.24 | 26320211 | |
216 | Phosphorylation | NGKDLKPSTPRSKGQ CCCCCCCCCCCCHHH | 49.83 | 27566939 | |
217 | Phosphorylation | GKDLKPSTPRSKGQE CCCCCCCCCCCHHHH | 31.11 | 26824392 | |
220 | Phosphorylation | LKPSTPRSKGQESFK CCCCCCCCHHHHHHH | 42.20 | 26745281 | |
221 | Acetylation | KPSTPRSKGQESFKK CCCCCCCHHHHHHHC | 66.93 | 15620105 | |
225 | Phosphorylation | PRSKGQESFKKQEKT CCCHHHHHHHCCCCC | 34.18 | 26824392 | |
227 | Acetylation | SKGQESFKKQEKTPK CHHHHHHHCCCCCCC | 63.93 | 68507 | |
228 | Acetylation | KGQESFKKQEKTPKT HHHHHHHCCCCCCCC | 62.77 | 12563253 | |
231 | Acetylation | ESFKKQEKTPKTPKG HHHHCCCCCCCCCCC | 68.58 | - | |
232 | Phosphorylation | SFKKQEKTPKTPKGP HHHCCCCCCCCCCCC | 29.30 | 26239621 | |
235 | Phosphorylation | KQEKTPKTPKGPSSV CCCCCCCCCCCCCCH | 31.28 | 26239621 | |
237 | Malonylation | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | 26320211 | |
237 | Ubiquitination | EKTPKTPKGPSSVED CCCCCCCCCCCCHHH | 84.45 | - | |
240 | Phosphorylation | PKTPKGPSSVEDIKA CCCCCCCCCHHHHHH | 56.54 | 23684622 | |
241 | Phosphorylation | KTPKGPSSVEDIKAK CCCCCCCCHHHHHHH | 32.43 | 27087446 | |
246 | Ubiquitination | PSSVEDIKAKMQASI CCCHHHHHHHHHHHH | 55.03 | - | |
248 | Ubiquitination | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | - | |
248 | Acetylation | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | - | |
248 | Malonylation | SVEDIKAKMQASIEK CHHHHHHHHHHHHHC | 26.92 | 26320211 | |
249 | Oxidation | VEDIKAKMQASIEKG HHHHHHHHHHHHHCC | 4.87 | 17203969 | |
252 | Phosphorylation | IKAKMQASIEKGGSL HHHHHHHHHHCCCCC | 17.87 | 22942356 | |
255 | Ubiquitination | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | - | |
255 | Acetylation | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | 23806337 | |
255 | Malonylation | KMQASIEKGGSLPKV HHHHHHHCCCCCCHH | 67.89 | 26320211 | |
258 | Phosphorylation | ASIEKGGSLPKVEAK HHHHCCCCCCHHHHH | 50.60 | 26824392 | |
261 | Ubiquitination | EKGGSLPKVEAKFIN HCCCCCCHHHHHHHH | 58.98 | - | |
265 | Acetylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 23806337 | |
265 | Succinylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 23806337 | |
265 | Ubiquitination | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | - | |
265 | Malonylation | SLPKVEAKFINYVKN CCCHHHHHHHHHHHH | 33.02 | 26320211 | |
271 | Ubiquitination | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | - | |
271 | Acetylation | AKFINYVKNCFRMTD HHHHHHHHHHHHCCC | 37.32 | 23806337 | |
273 | Glutathionylation | FINYVKNCFRMTDQE HHHHHHHHHHCCCHH | 1.57 | 24333276 | |
277 | Phosphorylation | VKNCFRMTDQEAIQD HHHHHHCCCHHHHHH | 30.21 | - | |
290 | Acetylation | QDLWQWRKSL----- HHHHHHHHHC----- | 53.82 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
4 | S | Phosphorylation | Kinase | PLK1 | Q07832 | Uniprot |
4 | S | Phosphorylation | Kinase | PLK2 | P53351 | Uniprot |
48 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
88 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
95 | T | Phosphorylation | Kinase | PKACA | P17612 | PSP |
125 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
125 | S | Phosphorylation | Kinase | PKACA | P17612 | PSP |
198 | T | Phosphorylation | Kinase | CDK1 | P11440 | Uniprot |
198 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
198 | T | Phosphorylation | Kinase | CDK2 | P97377 | Uniprot |
217 | T | Phosphorylation | Kinase | CDK1 | P11440 | Uniprot |
232 | T | Phosphorylation | Kinase | CDK1 | P11440 | Uniprot |
235 | T | Phosphorylation | Kinase | CDK1 | P11440 | Uniprot |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
4 | S | Phosphorylation |
| - |
4 | S | Phosphorylation |
| - |
4 | S | Phosphorylation |
| - |
70 | S | Phosphorylation |
| - |
125 | S | Phosphorylation |
| - |
198 | T | Phosphorylation |
| - |
198 | T | Phosphorylation |
| - |
198 | T | Phosphorylation |
| - |
198 | T | Phosphorylation |
| - |
217 | T | Phosphorylation |
| - |
232 | T | Phosphorylation |
| - |
235 | T | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NPM_MOUSE !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. | |
"The phagosomal proteome in interferon-gamma-activated macrophages."; Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,Thibault P.; Immunity 30:143-154(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70 AND SER-125, AND MASSSPECTROMETRY. | |
"Solid tumor proteome and phosphoproteome analysis by high resolutionmass spectrometry."; Zanivan S., Gnad F., Wickstroem S.A., Geiger T., Macek B., Cox J.,Faessler R., Mann M.; J. Proteome Res. 7:5314-5326(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70, AND MASSSPECTROMETRY. | |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-258, AND MASSSPECTROMETRY. | |
"Comprehensive identification of phosphorylation sites in postsynapticdensity preparations."; Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R.,Burlingame A.L.; Mol. Cell. Proteomics 5:914-922(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125, AND MASSSPECTROMETRY. | |
"Identification of phosphoproteins and their phosphorylation sites inthe WEHI-231 B lymphoma cell line."; Shu H., Chen S., Bi Q., Mumby M., Brekken D.L.; Mol. Cell. Proteomics 3:279-286(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-252 AND SER-258, ANDMASS SPECTROMETRY. |